These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19532101)

  • 21. Heart failure and diabetes.
    Bala C; Hâncu N
    Rom J Intern Med; 2004; 42(2):267-75. PubMed ID: 15529617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microalbuminuria: do we need a new threshold?
    Zamora CR; Cubeddu LX
    J Hum Hypertens; 2009 Feb; 23(2):146-9. PubMed ID: 18784737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for the use of urinary albumin as marker of kidney involvement in unselected populations.
    McQueen MJ
    Scand J Clin Lab Invest Suppl; 2008; 241():52-6. PubMed ID: 18569965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Microalbuminuria--underestimated cardiovascular risk factor].
    Nowicki M; Smoleń E; Szklarek M
    Przegl Lek; 2005; 62 Suppl 2():15-8. PubMed ID: 16623111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Microalbuminuria].
    Olsen MH; Ibsen H; Mogensen CE
    Ugeskr Laeger; 2009 Jun; 171(25):2097-100. PubMed ID: 19671389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors.
    Ascenção R; Fortuna P; Reis I; Carneiro AV
    Rev Port Cardiol; 2008 Sep; 27(9):1169-87. PubMed ID: 19044179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microalbuminuria in nondiabetic and nonhypertensive systolic heart failure patients.
    Figueiredo EL; Leão FV; Oliveira LV; Moreira MC; Figueiredo AF
    Congest Heart Fail; 2008; 14(5):234-8. PubMed ID: 18983285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of albuminuria as a prognostic indicator in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Niizeki T; Takeishi Y; Sasaki T; Kaneko K; Sugawara S; Watanabe T; Kubota I
    Am J Cardiol; 2013 Apr; 111(8):1180-6. PubMed ID: 23351461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.
    Sciarretta S; Paneni F; Palano F; Chin D; Tocci G; Rubattu S; Volpe M
    Clin Sci (Lond); 2009 Mar; 116(6):467-77. PubMed ID: 19200056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Urinary albumin excretion and coronary artery disease].
    Cirillo M; Stellato D; Lombardi C; Bilancio G; Chiricone D; De Santo NG
    G Ital Nefrol; 2006; 23 Suppl 34():S11-5. PubMed ID: 16633988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary prevention of heart failure: what is the evidence?
    Dupree CS
    Curr Opin Cardiol; 2009 Mar; 24(2):142-7. PubMed ID: 19532100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microalbuminuria: risk factor and potential therapeutic target for stroke?
    Ovbiagele B
    J Neurol Sci; 2008 Aug; 271(1-2):21-8. PubMed ID: 18514228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Microalbuminuria].
    Bouhanick B; Berrut G; Fressinaud P; Marre M
    Rev Prat; 1996 Jun; 46(12):1449-53. PubMed ID: 8881156
    [No Abstract]   [Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New techniques and laboratory examinations in the detection and evaluation of hypertension].
    Yasujima M
    Rinsho Byori; 2001 Mar; 49(3):257-60. PubMed ID: 11307325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing heart failure in patients with diabetes.
    Srikanthan P; Hsueh W
    Med Clin North Am; 2004 Sep; 88(5):1237-56. PubMed ID: 15331315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].
    Schmieder RE; Schrader J; Zidek W; Tebbe U; Bramlage P; Paar WD; Böhm M
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2665-71. PubMed ID: 17109277
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on microalbuminuria as a biomarker in renal and cardiovascular disease.
    Lambers Heerspink HJ; Brinkman JW; Bakker SJ; Gansevoort RT; de Zeeuw D
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):631-6. PubMed ID: 17053479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microalbuminuria.
    Khosla N; Sarafidis PA; Bakris GL
    Clin Lab Med; 2006 Sep; 26(3):635-53, vi-vii. PubMed ID: 16938588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.